Genbioma — Seed (estimated) · €525K

Navarrese biotech Genbioma, which develops probiotics and postbiotics from the human microbiome for conditions such as diabetes and obesity, raised €525K. The round was covered by the UN I+D+i Tech Transfer and Navarra Tech Transfer funds managed by Clave Mayor together with the women's angel network WA4STEAM, and will fund new clinical trials and the commercialisation of its pA1c®HI postbiotic.